Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

23 Dec 2010 08:15

Cubus Lux plc ("Cubus Lux" or the "Company") Issue of Equity

The Company today announces that it has issued 1,122,813 new ordinary shares of 10p each following the exercise of options at a price of 10p per option shares (the `Option Shares'). Consideration for the exercise of options is in lieu of unpaid fees.

The Option Shares represent 4.5 per cent of the Company's enlarged share capital and application has been made for their admission to trading on AIM. It is expected that dealings will commence at 8.00 am on 31 December 2010.

Following the exercise of options Milan Kotur and Hans Steinbichler will have interests of 1,672,024 and 1,217,141 representing 6.7 per cent and 4.9 per cent of the Company respectively. As a result of the option exercise, Directors Gerhard Huber, Christian Kaiser and Steve McCann have had their interests reduced to 15.7, 10.4 and 3 per cent respectively.

Following this issue of shares, the Group will have an issued share capital of 25,004,254 ordinary shares of 10p each. As the Group does not hold any ordinary shares in Treasury its total number of voting rights equals its capital. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.

For further information about the Company please see www.cubuslux.com orcontact:Cubus Lux plc Steve McCann +44 (0) 7787 183 184

Northland Capital Luke Cairns / Rod Venables +44 (0) 20 7492 4750 Partners Ltd (Nomad)

Hybridan LLP Claire Louise Noyce +44 (0) 20 7947 4350 (Broker)

vendor
Date   Source Headline
19th Jan 20247:00 amRNSNotice of Annual General Meeting
15th Jan 20247:00 amRNSDirector's Dealings
12th Jan 20247:00 amRNSDirector's Dealings
11th Jan 20247:00 amRNSChange of name and Focus on AI Beauty Opportunity
10th Jan 20247:00 amRNSDirector's Dealings
9th Jan 20247:00 amRNSDirector's Dealings
8th Jan 20247:00 amRNSChanges in Board Composition
3rd Jan 20245:22 pmRNSTR-1: Notification of major holdings
22nd Dec 20237:00 amRNSAnnual Results for the Year Ended 31 August 2023
5th Dec 20237:00 amRNSCellular Goods launch luxury festive gift sets
30th Nov 20234:05 pmRNSRejuvenating Face Serum receives Bronze Award
29th Nov 202312:15 pmRNSCellular Goods open shipping to 3 more EU markets
29th Nov 20237:00 amRNSCellular Goods nominated in Get The Gloss Awards
16th Nov 20237:00 amRNSCellular Goods open shipping to 4 more EU markets
15th Nov 20237:00 amRNSCellular Goods' products to launch on Chill.com
13th Nov 20237:00 amRNSKing Tide Carbon produce kelp-derived biochar
8th Nov 20237:00 amRNSCellular Goods product in Jamie Greenberg Swag Bag
6th Nov 20237:00 amRNSCellular Goods participate in Sephora’s Beauty Box
1st Nov 20237:00 amRNSCellular Goods open shipping to France and Germany
18th Oct 20237:00 amRNSCellular Goods launch in Sephora's sample programs
11th Oct 20237:00 amRNSKing Tide Carbon form JV with Springtide Seaweed
21st Sep 20237:00 amRNSCellular Goods is a finalist in Pure Beauty Awards
1st Aug 20237:00 amRNSCellular Goods open sales in France and Germany
17th Jul 20237:00 amRNSKing Tide Carbon Sign MOU with Springtide Seaweed
14th Jul 20236:23 pmRNSTR-1: Standard form for notification
19th Jun 20237:00 amRNSPayment partnership with Klarna
12th Jun 20236:15 pmRNSCorrection: Grant of Warrants
9th Jun 20237:00 amRNSGrant of Warrants
17th May 20237:00 amRNSProducts live on Sephora
12th May 20235:33 pmRNSDirector Dealings & TR-1 Notifications
10th May 20235:48 pmRNSGrant of Warrants
10th May 20237:00 amRNSProducts to launch on Sephora.co.uk
9th May 20237:00 amRNSAcquisition Completion
5th May 20237:00 amRNSInterim results
3rd May 20237:00 amRNSNotice of half-year results
4th Apr 20235:12 pmRNSGrant of Options and Warrants
1st Mar 20232:05 pmRNSSecond Price Monitoring Extn
1st Mar 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20235:50 pmRNSResults of Annual General Meeting
8th Feb 20237:00 amRNSTermination of proposed acquisition
2nd Feb 20237:00 amRNSAnnual General Meeting Update
31st Jan 20235:25 pmRNSTR-1: Standard notification of major holdings
24th Jan 20235:36 pmRNSTR-1: Standard notification of major holdings
19th Jan 20234:47 pmRNSNotice of Annual General Meeting
17th Jan 20234:49 pmRNSTR-1: Standard notification of major holdings
6th Jan 20235:04 pmRNSBoard changes
5th Jan 20234:57 pmRNSTR-1: Standard notification of major holdings
5th Jan 20234:56 pmRNSTR-1: Standard notification of major holdings
3rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
3rd Jan 20232:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.